Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 18, 2024 |
| PDB ID | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 8HPL | I7G6S2 | LpqY-SugABC in state 1 | |
| 8HPL | A0R2C1 | LpqY-SugABC in state 1 | |
| 8HPL | A0R2C0 | LpqY-SugABC in state 1 | |
| 8HPL | A0R2C3 | LpqY-SugABC in state 1 | |
| 8HPM | I7G6S2 | LpqY-SugABC in state 2 | |
| 8HPM | A0R2C1 | LpqY-SugABC in state 2 | |
| 8HPM | A0R2C0 | LpqY-SugABC in state 2 | |
| 8HPM | A0R2C3 | LpqY-SugABC in state 2 | |
| 8HPN | I7G6S2 | LpqY-SugABC in state 3 | |
| 8HPN | A0R2C1 | LpqY-SugABC in state 3 | |
| 8HPN | A0R2C0 | LpqY-SugABC in state 3 | |
| 8HPN | A0R2C3 | LpqY-SugABC in state 3 | |
| 8HPR | I7G6S2 | LpqY-SugABC in state 4 | |
| 8HPR | A0R2C1 | LpqY-SugABC in state 4 | |
| 8HPR | A0R2C0 | LpqY-SugABC in state 4 | |
| 8HPR | A0R2C3 | LpqY-SugABC in state 4 | |
| 8HPS | I7G6S2 | LpqY-SugABC in state 5 | |
| 8HPS | A0R2C1 | LpqY-SugABC in state 5 | |
| 8HPS | A0R2C0 | LpqY-SugABC in state 5 | |
| 8HPS | A0R2C3 | LpqY-SugABC in state 5 | |
| 8HQ8 | 8HQ8 | Bry-LHCII homotrimer of Bryopsis corticulans | |
| 8K3U | P08004 | S. cerevisiae Chs1 in complex with UDP and GlcNAc | |
| 8SO3 | P18627 | CryoEM structure of a therapeutic antibody (favezelimab) bound to human LAG3 | |
| 8SO3 | 8SO3 | CryoEM structure of a therapeutic antibody (favezelimab) bound to human LAG3 | |
| 8SR0 | P18627 | CryoEM structure of a therapeutic antibody (favezelimab) bound to human LAG3 local refined | |
| 8SR0 | 8SR0 | CryoEM structure of a therapeutic antibody (favezelimab) bound to human LAG3 local refined | |
| 8SUR | Q6P9J9 | TMEM16F bound with Niclosamide | |
| 8TAG | Q6P9J9 | TMEM16F, with Calcium and PIP2, no inhibitor | |
| 8TAI | Q6P9J9 | TMEM16F, with Calcium and PIP2, no inhibitor, Cl2 | |
| 8TAL | Q6P9J9 | TMEM16F, with Calcium and PIP2, no inhibitor, Cl1 | |
| 8TP2 | A3KF33 | H2 hemagglutinin (A/Singapore/1/1957) in complex with RBS-targeting 1-1-1F05 | |
| 8TP2 | 8TP2 | H2 hemagglutinin (A/Singapore/1/1957) in complex with RBS-targeting 1-1-1F05 | |
| 8TP3 | Q6WG00 | H1 hemagglutinin (NC99) in complex with RBS-targeting Fab 1-1-1F05 | |
| 8TP3 | 8TP3 | H1 hemagglutinin (NC99) in complex with RBS-targeting Fab 1-1-1F05 | |
| 8TP4 | A3KF33 | H2 hemagglutinin (A/Singapore/1/1957) in complex with RBS-targeting Fab 1-1-1E04 | |
| 8TP4 | 8TP4 | H2 hemagglutinin (A/Singapore/1/1957) in complex with RBS-targeting Fab 1-1-1E04 | |
| 8TP5 | Q6WG00 | H1 hemagglutinin (NC99) in complex with RBS-targeting Fab 1-1-1E04 | |
| 8TP5 | 8TP5 | H1 hemagglutinin (NC99) in complex with RBS-targeting Fab 1-1-1E04 | |
| 8TP6 | A3KF33 | H2 hemagglutinin (A/Singapore/1/1957) in complex with RBS-targeting Fab 4-1-1E02 | |
| 8TP6 | 8TP6 | H2 hemagglutinin (A/Singapore/1/1957) in complex with RBS-targeting Fab 4-1-1E02 | |
| 8TP7 | A3KF33 | H2 hemagglutinin (A/Singapore/1/1957) in complex with Sa-targeting Fab 4-1-1G03 | |
| 8TP7 | 8TP7 | H2 hemagglutinin (A/Singapore/1/1957) in complex with Sa-targeting Fab 4-1-1G03 | |
| 8TP9 | A3KF33 | H2 hemagglutinin (A/Singapore/1/1957) in complex with medial-junction-targeting Fab 2-2-1G06 | |
| 8TP9 | 8TP9 | H2 hemagglutinin (A/Singapore/1/1957) in complex with medial-junction-targeting Fab 2-2-1G06 | |
| 8TPA | Q6WG00 | H1 hemagglutinin (NC99) in complex with medial-junction-targeting Fab 2-2-1G06 | |
| 8TPA | 8TPA | H1 hemagglutinin (NC99) in complex with medial-junction-targeting Fab 2-2-1G06 | |
| 7XOE | P0DTC2 | Cryo-EM structure of S glycoprotein encoded by the Covid-19 mRNA vaccine candidate RQ3013 (Prefusion state) | |
| 7XOE | 7XOE | Cryo-EM structure of S glycoprotein encoded by the Covid-19 mRNA vaccine candidate RQ3013 (Prefusion state) | |
| 7XOE | P0DTC2 | Cryo-EM structure of S glycoprotein encoded by the Covid-19 mRNA vaccine candidate RQ3013 (Prefusion state) | |
| 7XOE | 7XOE | Cryo-EM structure of S glycoprotein encoded by the Covid-19 mRNA vaccine candidate RQ3013 (Prefusion state) |
